Bone and brain metastasis in lung cancer: recent advances in therapeutic strategies

A randomized, double-blind, placebo-controlled, phase IIIb trial (ATLAS) comparing bevacizumab (B) therapy with or without erlotinib (E) after completion of chemotherapy with B for first-line treatment of locally advanced, recurrent, or metastatic non-small cell lung cancer (NSCLC)

(2017) V. A. Miller et al.   JOURNAL OF CLINICAL ONCOLOGY

Neuropathic pain in cancer

(2013) M.T. Fallon   BRITISH JOURNAL OF ANAESTHESIA

Phase II study of Ginkgo biloba in irradiated brain tumor patients: effect on cognitive function, quality of life, and mood

(2012) Albert Attia et al.   JOURNAL OF NEURO-ONCOLOGY

An evidence-based review of the incidence of CNS bleeding with anti-VEGF therapy in non-small cell lung cancer patients with brain metastases

(2012) Alan Sandler et al.   LUNG CANCER

Efficacy of epidermal growth factor receptor tyrosine kinase inhibitors for brain metastasis in non-small cell lung cancer patients harboring either exon 19 or 21 mutation

(2012) S.J. Park et al.   LUNG CANCER

Pemetrexed and cisplatin as first-line chemotherapy for advanced non-small-cell lung cancer (NSCLC) with asymptomatic inoperable brain metastases: a multicenter phase II trial (GFPC 07-01)

(2011) F. Barlesi et al.   ANNALS OF ONCOLOGY

A meta-analysis of 18FDG-PET–CT, 18FDG-PET, MRI and bone scintigraphy for diagnosis of bone metastases in patients with lung cancer

(2011) Xinhua Qu et al.   EUROPEAN JOURNAL OF RADIOLOGY

Randomized, Double-Blind Study of Denosumab Versus Zoledronic Acid in the Treatment of Bone Metastases in Patients With Advanced Cancer (Excluding Breast and Prostate Cancer) or Multiple Myeloma

(2011) David H. Henry et al.   JOURNAL OF CLINICAL ONCOLOGY

Metastatic non-small-cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

(2010) G. D'Addario et al.   ANNALS OF ONCOLOGY

Denosumab Compared With Zoledronic Acid for the Treatment of Bone Metastases in Patients With Advanced Breast Cancer: A Randomized, Double-Blind Study

(2010) Alison T. Stopeck et al.   JOURNAL OF CLINICAL ONCOLOGY

Osteoblastic Response in Patients with Non-small Cell Lung Cancer with Activating EGFR Mutations and Bone Metastases during Treatment with EGFR Kinase Inhibitors

(2010) Sascha Ansén et al.   Journal of Thoracic Oncology

Outcomes Associated with Brain Metastases in a Three-Arm Phase III Trial of Gemcitabine-Containing Regimens Versus Paclitaxel Plus Carboplatin for Advanced Non-small Cell Lung Cancer

(2010) Martin J. Edelman et al.   Journal of Thoracic Oncology

Cisplatin, fotemustine and whole-brain radiotherapy in non-small cell lung cancer patients with asymptomatic brain metastases: A multicenter phase II study of the Gruppo Oncologico Italia Meridionale (GOIM 2603)

(2010) D. Galetta et al.   LUNG CANCER

Predictors of skeletal-related events in non-small cell lung cancer patients with bone metastases

(2010) Jong-Mu Sun et al.   LUNG CANCER

A phase III trial of topotecan and whole brain radiation therapy for patients with CNS-metastases due to lung cancer

(2009) T Neuhaus et al.   BRITISH JOURNAL OF CANCER

Epidermal growth factor signalling and bone metastasis

(2009) X Lu et al.   BRITISH JOURNAL OF CANCER

The changing landscape of the medical management of skeletal metastases in nonsmall cell lung cancer

(2009) John Kosteva et al.   CURRENT OPINION IN ONCOLOGY

ADAMTS1 and MMP1 proteolytically engage EGF-like ligands in an osteolytic signaling cascade for bone metastasis

(2009) X. Lu et al.   GENES & DEVELOPMENT

The impact of zoledronic acid therapy in survival of lung cancer patients with bone metastasis

(2009) Kostantinos Zarogoulidis et al.   INTERNATIONAL JOURNAL OF CANCER

Carcinomatous Meningitis in Non–Small-Cell Lung Cancer: Response to High-Dose Erlotinib

(2009) Nirav Dhruva et al.   JOURNAL OF CLINICAL ONCOLOGY

Safety of Bevacizumab in Patients With Non–Small-Cell Lung Cancer and Brain Metastases

(2009) Mark A. Socinski et al.   JOURNAL OF CLINICAL ONCOLOGY

Methodology used to develop the AANS/CNS management of brain metastases evidence-based clinical practice parameter guidelines

(2009) Paula D. Robinson et al.   JOURNAL OF NEURO-ONCOLOGY

The role of prophylactic anticonvulsants in the management of brain metastases: a systematic review and evidence-based clinical practice guideline

(2009) Tom Mikkelsen et al.   JOURNAL OF NEURO-ONCOLOGY

Efficacy comparison between 18F-FDG PET/CT and bone scintigraphy in detecting bony metastases of non-small-cell lung cancer

(2009) Jin Woo Song et al.   LUNG CANCER

Epidermal growth factor receptor tyrosine kinase inhibitors as a first-line therapy for never-smokers with adenocarcinoma of the lung having asymptomatic synchronous brain metastasis

(2009) Jeong-Eun Kim et al.   LUNG CANCER

Can upfront systemic chemotherapy replace stereotactic radiosurgery or whole brain radiotherapy in the treatment of non-small cell lung cancer patients with asymptomatic brain metastases?

(2009) Kyoung Ha Kim et al.   LUNG CANCER

Activity of Pemetrexed on brain metastases from Non-Small Cell Lung Cancer

(2009) Alessandra Bearz et al.   LUNG CANCER

Translational medicine: cancer pain mechanisms and management

(2008) A. Delaney et al.   BRITISH JOURNAL OF ANAESTHESIA

An Update on the Treatment of CNS Metastases in Small Cell Lung Cancer

(2008) William A. Castrucci et al.   CANCER JOURNAL

Predictors of Survival in Patients With Bone Metastasis of Lung Cancer

(2008) Hideshi Sugiura et al.   CLINICAL ORTHOPAEDICS AND RELATED RESEARCH

Zoledronic Acid and Survival in Patients with Metastatic Bone Disease from Lung Cancer and Elevated Markers of Osteoclast Activity

(2008) Vera Hirsh et al.   Journal of Thoracic Oncology

Risk factors for skeletal-related events in patients with non-small cell lung cancer treated by chemotherapy

(2008) Ikuo Sekine et al.   LUNG CANCER